Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.08.2022 | Case report

Brentuximab-vedotin

Splinter nail haemorrhages and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Filipovic N, et al. Brentuximab-induced splinter nail haemorrhages in a patient with Sezary syndrome: A case report. British Journal of Clinical Pharmacology 88: 3883-3886, No. 8, Aug 2022. Available from: URL: http://doi.org/10.1111/bcp.15247 Filipovic N, et al. Brentuximab-induced splinter nail haemorrhages in a patient with Sezary syndrome: A case report. British Journal of Clinical Pharmacology 88: 3883-3886, No. 8, Aug 2022. Available from: URL: http://​doi.​org/​10.​1111/​bcp.​15247
Metadaten
Titel
Brentuximab-vedotin
Splinter nail haemorrhages and lack of efficacy: case report
Publikationsdatum
01.08.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-21094-x

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Dapsone

Case report

Risperidone